We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
RHOFADE Mayne Pharma International Pty Ltd
Product name
RHOFADE
Accepted date
Jul-2025
Active ingredients
oxymetazoline hydrochloride
Summary of proposed indication
Rhofade (oxymetazoline hydrochloride) is a topical treatment for ongoing facial redness caused by rosacea in adults. Rosacea is a chronic inflammatory skin condition that primarily affects the face.
Application type
C (new indication)
Publication date
Jul-2025